Tag Archives: administrative law judge

DEA to Propose Significant Regulatory Changes in the Coming Year

The Department of Justice recently published its list of proposed regulatory actions for the near and long term.  It appears that the Drug Enforcement Administration’s (DEA’s) Regulatory Drafting and Support Section is going to have a busy year.  The Unified Agenda indicates several potential regulatory changes are in store for the coming year, some of … Continue Reading

Are DEA Administrative Hearings Fundamentally Unfair to Registrants?

While a great deal of attention is given to DEA Chief Administrative Law Judge Mulrooney’s (“CALJ Mulrooney’s”) opinion regarding the impact of the Ensuring Patient Access and Effective Drug Enforcement Act on DEA enforcement efforts, very little attention has been afforded a shocking and unprecedented attack by a sitting DEA Administrative Law Judge on DEA’s … Continue Reading

DEA Decisions: Evidence of “Red Flags” of Drug Diversion

On November 10, 2016, the DEA issued its final decision and order in the case against Jones Total Health Care Pharmacy, L.L.C. (“Jones Pharmacy”) and SND Health Care L.L.C. (“SND”). The Administrator ordered that the DEA deny Jones Pharmacy’s registration renewal application and also deny SND’s pending registration application. These orders were consistent with the … Continue Reading

DEA Decisions: In the Matter of The Medicine Shoppe

In the Matter of the Medicine Shoppe (October 2, 2014) DEA recently revoked the registration of the Medicine Shoppe, a San Antonio, Texas,  pharmacy, based on a finding that the pharmacy violated the Controlled Substances Act in all of the following ways: dispensed controlled substances without a prescription; dispensed controlled substances when the prescription was “signed” … Continue Reading

DEA Decisions: In the Matter of Moore Clinical Trials, L.L.C.

In the Matter of Moore Clinical Trials, L.L.C (July 11, 2014) DEA last month denied the DEA research registration application of an Arkansas clinical research company, finding that the person who would be primarily responsible for ordering and storing controlled substances had a “shocking” lack of knowledge of the fundamental requirements imposed by the Controlled … Continue Reading

DEA Decisions: In the Matter of Kenneth Harold Bull, M.D.

In the Matter of Kenneth Harold Bull, M.D. (October 22, 2013) Dr. Kenneth Bull is a New Mexico psychiatrist known for treating difficult or complex psychiatric conditions.  During his long career, Dr. Bull worked as the chief of psychiatry or medical director of psychiatric services at nearly every hospital in the Albuquerque area, and he … Continue Reading

DEA Decisions: In the Matter of Gabriel Sanchez

In the Matter of Gabriel Sanchez, M.D. (September 25, 2013) On July 15 2010, Dr. Gabriel Sanchez issued prescriptions for oxycodone (Schedule II) and carisoprodol (Schedule IV) to two undercover law enforcement officers.  During the visits with both undercover officers, Dr. Sanchez failed to take complete medical histories, failed to make serious inquiries into the … Continue Reading

DEA Decisions: In the Matter of S&S Pharmacy, Inc., d/b/a Platinum Pharmacy & Compounding

In the Matter of S&S Pharmacy, Inc., d/b/a Platinum Pharmacy & Compounding (Sept. 19, 2013) In 2011, Ihab S. Barsoum, the owner and pharmacist-in-charge of S&S Pharmacy, Inc., d/b/a Platinum Pharmacy & Compounding (“Platinum Pharmacy”), engaged in what the Administrator described as “blatant drug deal(s) and [] distribution(s).”  On five occasions between January and June … Continue Reading

DEA Decisions: In the Matter of Kevin Dennis, M.D.

In the Matter of Kevin Dennis, M.D. (August 26, 2013) In 2007, Dr. Kevin Dennis became involved with an Internet prescribing company known as “Telemed Ventures.”  Between 2007 and 2008, Dr. Dennis (who was licensed and registered in Tennessee only) issued numerous prescriptions to individuals located in other states without seeing them or performing any … Continue Reading

DEA Decisions: In the Matter of Mireille Lalanne

In the Matter of Mireille Lalanne, M.D., 78 Fed. Reg. 47,750 (August 6, 2013) Dr. Lalanne is a physician who, sometime before November 2008, became involved in an organized crime scheme.  Her role?  Dr. Lalanne provided controlled substance prescriptions to different syndicates for illegal distribution.  In November 2008, Dr. Lalanne was indicted by a Kentucky … Continue Reading

DEA Decisions: In the Matter of Tyson D. Quy

Editor’s note: This post is the first in our new “DEA Decisions” series where we will provide summaries of Final Orders issued by the DEA on administrative matters litigated before the agency. We hope they are helpful to you — let us know!   In the Matter of Tyson D. Quy, M.D., 78 Fed. Reg. … Continue Reading
LexBlog